Innoviva (INVA) Tax Rate Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,119.00 |
| Sep 30, 2025 | -7,421.00 |
| Jun 30, 2025 | 58.00 |
| Mar 31, 2025 | -3,979.00 |
| Sep 30, 2024 | 7,774.00 |
| Jun 30, 2024 | -6,582.00 |
| Mar 31, 2024 | 381.00 |
| Sep 30, 2023 | -1,538.00 |
| Jun 30, 2023 | 8,191.00 |
| Mar 31, 2023 | -9.00 |
| Sep 30, 2022 | 328.00 |
| Jun 30, 2022 | -2,297.00 |
| Mar 31, 2022 | 12.00 |
| Sep 30, 2021 | -99.00 |
| Jun 30, 2021 | 173.00 |
| Mar 31, 2021 | -154.00 |
| Dec 31, 2020 | -31.00 |
| Sep 30, 2020 | -70.00 |
| Jun 30, 2020 | -162.00 |
| Mar 31, 2020 | -76.00 |
| Dec 31, 2019 | 28,572.00 |
| Dec 31, 2018 | -26,808.00 |